US 10881630
Creatine oral supplementation using creatine hydrochloride salt
granted A61KA61K31/185A61K31/195
Quick answer
US patent 10881630 (Creatine oral supplementation using creatine hydrochloride salt) held by BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA expires Mon Dec 31 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA
- Grant date
- Tue Jan 05 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Dec 31 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 20
- CPC classes
- A61K, A61K31/185, A61K31/195, A61K31/198, A61K31/661